MyMetabolon Login
© 2020 Metabolon, Inc. All rights reserved.
Metabolon Metabolon
  • Metabolomics
    • About Metabolomics
    • Our Process
    • Technology & Knowledgebase
    • Setting the Standard: The 4Cs
    • Our Latest Insights
  • Solutions
    • Column 1
      • Products & Services
        • Global Metabolomics
        • Lipidomics
        • Targeted Assays
        • Study Design & Consulting
        • Sample Preparation & Handling
        • Study Success Sample Handling Kit
        • Reporting & Interpretation
        • Bioinformatics
        • MyMetabolon Client Portal
    • Column 2
      • By Research & Development Phase
        • Discovery & Target Selection
        • Lead Candidate Selection
        • Preclinical
        • Clinical Development
        • Manufacturing & Bioprocessing
    • Column 3
      • By Therapeutic Area
        • Cardiovascular Disease
        • COVID-19
        • Diabetes
        • Gastrointestinal
        • Liver Disease
        • Microbiome
        • Neuroscience
        • Oncology
        • Renal & Urological Disorders
        • Respiratory Disorders
    • Column 4
      • By Sector
        • Academic
        • Agriculture
        • Biotech / Pharmaceutical
        • Precision Medicine
        • Nutrition
        • Personal Care & Cosmetics
        • Population Health
        • Veterinary & Animal Health
  • Insights
    • Our Latest Insights
    • Blog
    • News & Events
  • Resources
    • Resource Library
    • Client Stories
    • COVID-19
  • Company
    • About Us
    • Working With Us (FAQ)
    • Leadership
    • Careers
    • Strategic Partnering
    • News & Events
    • Contact Us
MyMetabolon
Demo Our Data
Metabolon
Demo Our Data

Oncology

Drive outcomes in oncology

Dysregulated metabolism is not only essential for the growth and proliferation of individual cancer cells; indeed, the physiology of the patient is as much a part of the equation as the tumor. Metabolomics can both identify cancer-specific drug targets and assess the patient’s phenotype more broadly, addressing key questions like who will respond to the therapy? How can we expand the pool of responders? How can we predict adverse events? Overall, metabolomics informs decision-making and positions development programs for success by providing a functional readout of the molecular phenotype.

TALK WITH AN EXPERT
See More Solutions
Target biology

Drug development in oncology often suffers from “Achilles heel” traits such as an absence of human genetic data linking the target to the disease, lack of access to a well-validated animal model of the disease or poor understanding of the target’s role in the underlying disease pathophysiology. Metabolomics has the capacity to arm your program for success by illuminating the right target through profound mechanistic understanding of the disease state.

Lead selection and optimization

It’s not always easy to predict toxicity from preclinical data or to demonstrate clear drug exposure and pharmacological activity on the target organ, but metabolomics can help ensure the right exposure and right safety profile by providing early biomarkers of both on- and off-target activity and toxicity.

Clinical success

A lack of efficacy biomarkers and an inability to stratify patients are among the leading causes of project failure. Metabolomics delivers the transformational key to identify the right patients & biomarkers as well as the right commercial potential.

Delve deeper into role of metabolites in immuno-oncology

The critical influence of the gut microbiome on the efficacy of immuno-oncology drugs is now well-established. How do microbes in the gut drive patient response in distal organs? Metabolomics provides a key piece of the puzzle by profiling the chemical signals that mediate the microbial modulation of host immunity. What’s more, the importance of metabolic reprogramming in T cell activation makes metabolomics a crucial tool in the development of robust and reproducible manufacturing processes for CAR-T and other cell-based therapies.

Reference: Based on AstraZeneca’s five-dimensional framework Cook, D, et al. Nat Rev Drug Discov 13, 419–431 (2014).

Study Design

Data Interpretation

Our Platform

Learn More

Related Resources

See All Resources
Overcoming Challenges in Microbiome Research: A Panel Discussion

Overcoming Challenges in Microbiome Research: A Panel Discussion

Global Metabolomics, Immunology & Inflammation, Microbiome, Nutrition, Oncology, Personal Care & Cosmetics, Targeted Assays, Veterinary & Animal Health, Webinars
A Metabolomics Analysis of Body Mass Index and Postmenopausal Breast Cancer Risk

A Metabolomics Analysis of Body Mass Index and Postmenopausal Breast Cancer Risk

Oncology, Publications
Clonal evolution mechanisms in NT5C2 mutant-relapsed acute lymphoblastic leukaemia

Clonal evolution mechanisms in NT5C2 mutant-relapsed acute lymphoblastic leukaemia

Oncology, Publications
Load more

Enlighten your research,
accelerate your discovery.

Demo Our Data
or Talk With an Expert

Metabolomics

  • About Metabolomics
  • Our Process
  • Technology & Knowledgebase
  • Setting the Standard: The 4Cs
  • Insights & Discoveries

Solutions

  • Products & Services
  • By Research & Development Phase
  • By Therapeutic Area
  • By Sector

Insights

  • Our Latest Insights
  • Blog
  • News & Events

Resources

  • Resource Library
  • Client Stories
  • COVID-19

Company

  • About Us
  • Working With Us (FAQ)
  • Leadership
  • Careers
  • Strategic Partnering
  • News & Events
  • Contact Us
Metabolon - Logo - Enlightening Life

Metabolon provides actionable biological insights to answer the toughest questions in life sciences research and drug development.

© 2021 Metabolon, Inc. All rights reserved. Privacy & Terms

in
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.